COVID-19 Update: Read our messages to employees and clients

February 19, 2019
How the “Blue Wave” will Affect Healthcare
The anticipated “blue wave”—though not overwhelming, since Republicans actually strengthened their grip on the Senate—was substantial enough to give Democrats a significant majority in the House of Representatives. The shifting landscape is bound to affect healthcare legislation in the next couple of years, with a set of possibilities that range from virtually definite to extremely unlikely.

There’s no question that healthcare was on voters’ minds when they turned out in record numbers this past November. Of the more than 100 million who casted ballots, 41% said healthcare topped the list of important issues facing the country. That number was up from 25% in 2014 and a mere 18% in 2012.

And for Democrats, it was apparently a winning issue. Democratic candidates made healthcare the focus of roughly 50% of their advertising. The anticipated “blue wave”—though not overwhelming, since Republicans actually strengthened their grip on the Senate—was substantial enough to give Democrats a significant majority in the House of Representatives. Democrats also gained footholds in several states.

The shifting landscape is bound to affect healthcare legislation in the next couple of years, with a set of possibilities that range from virtually definite to extremely unlikely.


What’s definite?

In 2017, Republican efforts to repeal and replace Obamacare failed by the slimmest of margins. What now? “The most important consequence [of the election] is that the repeal of the Affordable Care Act is off the table until at least 2021,” says Matthew Fiedler, a fellow with the University of Southern California-Brookings Schaeffer Initiative on Health Policy.

In fact, it’s possible that some ACA provisions will be strengthened or restored. If House Democrats can recruit a handful of Senate Republicans, a bill proposed by top Democrats on three healthcare-related committees would expand premium subsidies by increasing tax credits for enrollees, among other things. The bill would also target short-term insurance plans, which don’t have to comply with all of Obamacare’s rules and which were intended to be used as stopgap plans only. In a move widely seen as an effort to weaken the ACA, the Trump administration has extended plan eligibility from three months to 12 months. The bill would also pump more money back into enrollment outreach.

It’s also possible that the Senate will revisit bipartisan efforts to lower premiums and stabilize insurance markets; the goal of a near-compromise worked out by Republican Lamar Alexander and Democrat Patty Murray last year. The effort ultimately fell apart over portions related to abortion, but Sen. Murray is calling on colleagues to resume bipartisan discussions.

Significant Medicaid expansion appears to be another definite. Voters in Idaho, Nebraska, and Utah approved proposals in favor of expansion, and with Democrats wining governorships in Wisconsin, Kansas and Maine, expansion in those states is virtually assured. (Maine voters had actually approved Medicaid expansion last year, but its outgoing Republican governor had effectively blocked it.)


What’s possible?

Democrats are expected to go after rising drug prices, and there are some indications that Republicans could be persuaded to go along. President Trump has promised to bring prices down, and Senate majority leader Mitch McConnell has said, “I can’t imagine that won’t be on the agenda.”

Under a Democratic plan, a new regulatory agency would have the power to fine drug manufacturers who enact “unconscionable” price hikes. Drug manufacturers would also be forced to justify price hikes of at least 300% over five years, or 100% over one year.

But Big Pharma hopes that a divided Congress will short-circuit any efforts. Brian Abrahams, of RBC Capital Markets, says the election results are a “best-case scenario” for the biotech sector and that stalemate is the most likely outcome.


What’s extremely unlikely?

Although many newly elected Democrats are on record favoring a completely revamped single-payer “Medicare for All” system, such a radical change remains a pipe dream as long as Republicans control the Senate and executive branch.

But some movement towards middle ground may be within the realm of possibility. Brian Higgins, a New York congressman since 2005, says he has secured an “agreement in principle” from returning House Speaker Nancy Pelosi that Democrats will undertake a “serious good faith effort” to lower the Medicare-eligibility age to 50.

That would be a win-win approach, argues Princeton professor Paul Starr. Those in the 50–64 age group would be guaranteed coverage if they retire early or can’t get employer coverage, and those under 50 would have access to more-affordable coverage, because they’d no longer be sharing risk with the more expensive older population.

Public support for increased government involvement in healthcare has risen steadily over the last several years, but public sentiment doesn’t always translate into legislative action.

Nurse Care Team Assistants
While nurses comprise the largest healthcare workforce, many suffer in silence from burnout and decreased job satisfaction. Our Nurse CTAs combat burnout with strategic support. From documenting patient encounters to monitoring vital signs, CTAs ensure nurses work top-of-license. CTAs close critical gaps in the care continuum and provide nurses with the added bandwidth to focus on critical care.

TeleScribe Services
Providers with limited space or in need of increased privacy on behalf of their patients have valuable documentation support through our real-time video TeleScribe program. Healthcare sites in rural settings also benefit from our unrivaled offsite resource for optimized efficiency and tackling administrative burdens.

Care Team Assistants
Our team of experts have developed innovative strategies from the industry insights gained from nearly two decades of healtchare leadership to improve care team performance. A tailored, next-generation CTA Program extends your ability to support patients throughout their care journey.

Care Navigators
As healthcare business models evolve, so should care teams. Patients who are paired with Care Navigators report feeling less anxiety, and an increased ability to self-manage their conditions between visits. And providers report increased job satisfaction from improved efficiency, and knowing their patients have access to care teams, and strategic support.

Revenue Cycle Management
Transition Revenue Cycle Management into the modern age with a suite of software tools that will transform your billing and coding processes. Transact at lightning speed, with increased transparency and decreased siloes. The QueueLogix software application seamlessly integrates with existing EMRs to ensure the clinical activities and back-office operations are well aligned, monitored and successful.

Referral Management
Minimize the number of patients referred out of network and provide a hassle-free experience for patients. With our referral management solutions, CTAs can check provider availability, insurance requirements and book an appointment for your patient at the point of care. Increase follow-up appointment compliance and preserve network integrity.

Scribe Services
There’s a reason why we’re the nation’s most frequently used scribe company: we offer professionally trained in-person and virtual medical scribes to meet the specific needs of our clients. We offer a variety of scribe programs, as well as technology and personnel solutions that address revenue cycle management, the transition to value-based care, and more through our HealthChannels family of companies.

Artificial Intelligence
Our advanced AI solutions tackle complex documentation challenges to reduce the administrative burden preventing doctors from delivering precision care. We'll guide you through the best practices for incorporating AI into your workflow. Gain visibility into your data with enhanced analytics driven by AI and CTAs.